Illumina, Inc. today announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research ...

Illumina, Inc. has announced that it is collaborating with the Wellcome Trust Sanger Institute (WTSI) and the Wellcome Trust Case-Control Consortium (WT-CCC) on the design of a custom Sentrix® ...

Illumina, Inc. today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide common and ...

The Genomics Core offers a variety of microarray analysis options for DNA and epigenetic studies. The Illumina BeadArray technology combined with the Illumina iScan Array Scanner allows for analysis ...

On Feb 16, we issued an updated research report on Illumina, Inc. ILMN. ... Total Microarray revenues were also down by 7.8%, the pandemic being one of the reasons behind it.

We offer Illumina microarray processing and expertise accessible to both internal and external researchers. All samples received are stored prior to analysis in a dedicated biobanking facility with 24 ...